Skip to content
10-Q

Quarterly Report

Ovid Therapeutics Inc. OVID

0001628280-25-040008

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 71.11M sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $53K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$15.05M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$30.94M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $28.42M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $26.3M
Stockholders Equity Q2 2025 · Jun 30, 2025 $55.79M
Stockholders Equity Q2 2025 · Mar 31, 2025 $59.28M
Stockholders Equity Q2 2025 · Dec 31, 2024 $68.23M
Stockholders Equity Q2 2025 · Jun 30, 2024 $88.9M
Stockholders Equity Q2 2025 · Mar 31, 2024 $78.28M
Stockholders Equity Q2 2025 · Dec 31, 2023 $87.8M
Current Liabilities Q2 2025 · Jun 30, 2025 $8.92M
Current Liabilities Q2 2025 · Dec 31, 2024 $10.52M
Total Liabilities Q2 2025 · Jun 30, 2025 $21.64M
Total Liabilities Q2 2025 · Dec 31, 2024 $23.94M
Current Assets Q2 2025 · Jun 30, 2025 $42.09M
Current Assets Q2 2025 · Dec 31, 2024 $55.94M
Total Assets Q2 2025 · Jun 30, 2025 $77.43M
Total Assets Q2 2025 · Dec 31, 2024 $92.17M
Rd Expense Q2 2025 · Jun 30, 2025 $6.47M
Rd Expense Q2 2025 · Jun 30, 2025 $13.12M
Rd Expense Q2 2025 · Jun 30, 2024 $12.58M
Rd Expense Q2 2025 · Jun 30, 2024 $22.98M
Net Income Q2 2025 · Jun 30, 2025 −$4.68M
Net Income Q2 2025 · Jun 30, 2025 −$14.92M
Net Income Q2 2025 · Mar 31, 2025 −$10.24M
Net Income Q2 2025 · Jun 30, 2024 $8.52M
Net Income Q2 2025 · Jun 30, 2024 −$3.17M
Net Income Q2 2025 · Mar 31, 2024 −$11.69M
Operating Income Q2 2025 · Jun 30, 2025 −$5.07M
Operating Income Q2 2025 · Jun 30, 2025 −$17.62M
Operating Income Q2 2025 · Jun 30, 2024 −$20.52M
Operating Income Q2 2025 · Jun 30, 2024 −$37.93M
Revenue Q2 2025 · Jun 30, 2025 $6.27M
Revenue Q2 2025 · Jun 30, 2025 $6.4M
Revenue Q2 2025 · Jun 30, 2024 $169K
Revenue Q2 2025 · Jun 30, 2024 $317K